Australia - English - Department of Health (Therapeutic Goods Administration)

blackmores ltd - ginkgo biloba, quantity: 120 mg (equivalent: ginkgo biloba, qty 6 g; equivalent: ginkgolides, qty 3.7 mg; equivalent: bilobalide, qty 3.5 mg; equivalent: ginkgo flavonglycosides, qty 29.4 mg) - tablet, film coated - excipient ingredients: hypromellose; iron oxide red; purified talc; microcrystalline cellulose; maize starch; titanium dioxide; croscarmellose sodium; lactose monohydrate; macrogol 1500; magnesium stearate; silicon dioxide - antioxidant/reduce free radicals formed in the body ; maintain/support healthy blood circulation ; maintain/support cognitive function/mental function ; maintain/support memory/mental recall

Israel - English - Ministry of Health

dr.samuelov importing & marketing ltd, israel - dry extract from ginkgo biloba leaves (35-67:1) - film coated tablets - dry extract from ginkgo biloba leaves (35-67:1) 120 mg - ginkgo biloba - • for the symptomatic treatment of mental losses due to organic brain syndrome within the framework of a general therapeutic concept for dementia syndromes having as major symptoms: deficient memory, disturbances of concentration, depressive mood, dizziness, tinnitus and headache.the primary target group includes patients with demential syndrome in primary degenerative dementia, vascular dementia and mixed forms of both.individual response to the treatment cannot be predicted.note: prior to starting treatment with ginkgo extract, clarification should be obtained as to whether the pathological symptoms encountered are not based on an underlying disease requiring a specific treatment.• vertigo of vascular and involutional origin.• adjuvant treatment in case of tinnitus of vascular and involutional origin.the following note for the patient is included in the instruction leaflet:“frequently occurring dizziness and tinnitus always need to be clarified by a physician. in case of sudden hearing deficit or hearing loss, you should immediately consult a physician.”

Ireland - English - HPRA (Health Products Regulatory Authority)

intersan gmbh - ginkgo biloba - film coated tablet - 40 milligram

Ireland - English - HPRA (Health Products Regulatory Authority)

abbott laboratories ireland ltd - ibuprofen - film coated tablet - 400 milligram

Ireland - English - HPRA (Health Products Regulatory Authority)

abbott laboratories ireland ltd - ibuprofen - film coated tablet - 600 milligram

Ireland - English - HPRA (Health Products Regulatory Authority)

abbott healthcare products ltd - dydrogesterone - film coated tablet - 10 milligram

Singapore - English - HSA (Health Sciences Authority)

united italian trading corporation (private) limited - ibuprofen (as l-arginine salt 770mg) - tablet, film coated - 400mg - ibuprofen (as l-arginine salt 770mg) 400mg

Ireland - English - HPRA (Health Products Regulatory Authority)

bgp products ltd - dydrogesterone - film coated tablet - 10 milligram - pregnadien derivatives - urinary system and sex hormones - in the management of conditions associated with progesterone insufficiency: dysmenorrhoea, endometriosis, infertility, irregular menstrual cycles and pre-menstrual syndrome. the drug may be used with an estrogen in the management of dysfunctional bleeding or secondary amenorrhoea, or in association with estrogen in hormone replacement therapy.

United Kingdom - English - myHealthbox

milpharm limited - efavirenz. - film-coated tablets - 600mg - non-nucleoside reverse transcriptase inhibitors - it is indicated in antiviral combination treatment of human immunodeficiency virus-1 (hiv-1) infected adults, adolescents and children 3 years of age and older.

Ireland - English - HPRA (Health Products Regulatory Authority)

mcneil healthcare (ireland) ltd - ibuprofen, pseudoephedrine hydrochloride - film coated tablet - 200/30 milligram - other cold preparations